Financial information

Read our latest press releases, financial reports and annual meeting materials.

Why Invest

The digitalisation of healthcare will be crucial able to meet the healthcare requirements of the future. In addition to the challenges that Covid-19 has brought with it, we are now seeing increasing patient volumes and limited financial resources in the healthcare sector. For an efficient and safe care, we need new ways of working and new technical innovations. As part of the development, more and more ambulance operations are switching over to electronic patient records and introducing systems that allow patient information to be shared in real time throughout the care chain. Primary care has also begun to implement solutions to be able to monitor and treat patients remotely to a greater extent. Developments in this segment for modern e-health solutions are progressing and are expected to accelerate in the coming years.

Ortivus has in-house development and production of monitoring equipment and is well equipped to meet the requirements of modern, adaptable and reliable healthcare solutions. With Ortivus’ MobiMed, you can review a patients’ vital sign such as ECG, blood pressure and heart rate in real time and at a distance. MobiMed facilitates diagnosis through advanced decision support and the ability to consult an expert remotely via video call or chat. With MobiMed, treatment can be started at an early stage while unnecessary hospital transports can be avoided as a large part of the care can take place outside the hospital. With its modularity, flexibility and advanced features, MobiMed is well adapted for our future healthcare.

Ortivus is today established in many countries and is well positioned to take MobiMed to an even larger international market.

The Ortivus Share

Ortivus shares have been listed on the NASDAQ Stockholm Small Cap-list since January 2, 1997.

Stock SymbolISINShares OutstandingVotes/shareTotal Number of Votes
Class AORTI ASE00001889301,662,6821016,626,820
Class BORTI BSE000012308542,644,786 142,644,786

The share capital is SEK 15,507,614. Share capital is divided between class A and class B shares. The number of shares outstanding is 44,307,468 of which class A amount to 1,662,682 and class B to 42,644,786. Every class A share carries 10 votes and every class B share carries one vote.

Ortivus A

Ortivus B

Hover the mouse over the graphs to see the share price at the corresponding date.

Ortivus’ Investors

Financial Reports

Yearly Reports

Quarterly Reports

Subscribe to Financial Information

IR Calendar

  • Interim report Q4:16/2-2024, 8:30 am
  • Annual report 2023: 28/3-2024, 8:30 am
  • Interim report Q1: 8/5-2024, 8:30 am
  • Annual General Meeting 2024: 8/5-2024, 3:00-4:00 pm
  • Interim report Q2: 23/8-2024, 8:30 am
  • Interim report Q3: 8/11-2024, 8:30 am
  • Interim report Q4: 14/2-2024, 8:30 am

Latest news